NCT02443818
- Conditions
- Segmental Overgrowth Disorders Due to PIK3CA
- Locations
-
- CHU d'Angers Angers, France
- CHU de Bordeaux - GH Pellegrin Bordeaux, France
- CHU de DIJON Dijon, France
- Hôpital Jeanne de Flandre Lille, France
Clinical trial condition
Segmental Overgrowth Disorders Due to PIK3CA
Explore clinical trials studying Segmental Overgrowth Disorders Due to PIK3CA. Study availability and eligibility vary by location and protocol.
1 public trial
0 recruiting studies